首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1820652

全球破傷風類毒素疫苗市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Tetanus Toxoid Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球破傷風類毒素疫苗市場預測將大幅成長，市場規模預計到 2033 年將飆升至 100.9 億美元，較 2024 年的 59.2 億美元大幅成長。這一擴張反映了 2025 年至 2033 年期間預計的 6.11% 的驚人年複合成長率(CAGR)。

在持續進行的免疫接種計畫以及孕產婦和新生兒破傷風消除行動的推動下，全球破傷風類毒素疫苗市場預計將穩定成長。疫苗配方和給藥方式的進步，包括聯合疫苗和無針技術，正在提高疫苗覆蓋率和依從性。未來的發展將著重於耐熱疫苗及其與數位免疫追蹤系統的整合。

此外，發展中國家醫療基礎設施的不斷完善和意識的提升正在擴大疫苗接種覆蓋範圍。世界衛生組織和全球疫苗免疫聯盟等組織的全球夥伴關係和資金支持大規模免疫接種運動。監管協調和品質控制正在提升疫苗的安全性和有效性。隨著公共衛生重點的不斷演變，破傷風類毒素疫苗市場將持續創新，提供可及、有效且永續的免疫解決方案。

依疫苗類型概述
依疫苗類型分析歷史和預測數據
破傷風類毒素（Tt）
白喉和破傷風（Dt）
破傷風和白喉（TD）
白喉、破傷風和百日咳 (DTAP)
破傷風、白喉和百日咳 (Tdap)
白喉、破傷風、百日咳、Hib 和B型肝炎 (Dtp-Hib-Hepb)
五價（Dtap-Ipv/Hib）
六價（Dtap-Ipv/Hib-Hepb）
其他疫苗類型

第6章：全球破傷風類毒素疫苗市場分析：依年齡層

按年齡層別概覽
按年齡層別進行的歷史和預測資料分析
兒科
成人

第7章：全球破傷風類毒素疫苗市場分析：依最終用途

按最終用途概述
按最終用途進行的歷史和預測數據分析
醫院和診所
政府組織
其他最終用戶

第 8 章：全球破傷風類毒素疫苗市場分析：按地區

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：破傷風類毒素疫苗公司的競爭格局

破傷風類毒素疫苗市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Bharat Biotech International Limited

公司概況
公司收入
產品
最新動態

Biological E. Limited

公司概況
公司收入
產品
最新動態

Biological Products Institute (BPI) Argentina

公司概況
公司收入
產品
最新動態

Chengdu Institute Of Biological Products Co. Ltd.

公司概況
公司收入
產品
最新動態

GlaxoSmithKline

公司概況
公司收入
產品
最新動態

Johnson & Johnson

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Mitsubishi Tanabe Pharma Corporation

公司概況
公司收入
產品
最新動態

Panacea Biotec

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Serum Institute Of India

公司概況
公司收入
產品
最新動態

Zydus Group

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112113431

The forecast for the global Tetanus Toxoid Vaccine market predicts substantial growth, with market size projected to soar to USD 10.09 Billion by 2033, a significant increase from the USD 5.92 Billion recorded in 2024. This expansion reflects an impressive compound annual growth rate (CAGR) of 6.11% anticipated between 2025 and 2033.

The global tetanus toxoid vaccine market is set for steady growth driven by ongoing immunization programs and maternal and neonatal tetanus elimination initiatives. Advances in vaccine formulation and delivery, including combination vaccines and needle-free technologies, are improving coverage and compliance. Future developments will focus on thermostable vaccines and integration with digital immunization tracking systems.

Moreover, increasing healthcare infrastructure and awareness in developing countries are expanding vaccination reach. Global partnerships and funding from organizations like WHO and GAVI are supporting mass immunization campaigns. Regulatory harmonization and quality control are enhancing vaccine safety and efficacy. As public health priorities evolve, the tetanus toxoid vaccine market will continue to innovate, delivering accessible, effective, and sustainable immunization solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Tetanus Toxoid Vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Vaccine Type

Tetanus Toxoid (Tt)
Diphtheria And Tetanus (Dt)
Tetanus And Diphtheria (Td)
Diphtheria, Tetanus, And Pertussis (Dtap)
Tetanus, Diphtheria, And Pertussis (Tdap)
Diphtheria, Tetanus, Pertussis, Hib And Hepatitis B (Dtp-Hib-Hepb)
Pentavalent (Dtap-Ipv/Hib)
Hexavalent (Dtap-Ipv/Hib-Hepb)
Other Vaccine Types

By Age Group

Pediatric
Adult

By End-Use

Hospitals And Clinics
Government Organizations
Other End-Users
List of Companies Profiled in the report
Bharat Biotech International Limited, Biological E. Limited, Biological Products Institute (BPI) Argentina, Chengdu Institute of Biological Products Co. Ltd., GlaxoSmithKline, Johnson & Johnson, Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Panacea Biotec, Pfizer Inc., Sanofi, Serum Institute of India, Zydus Group.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. TETANUS TOXOID VACCINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Vaccine Type
- 3.7.2 Market Attractiveness Analysis By Age Group
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL TETANUS TOXOID VACCINE MARKET ANALYSIS BY VACCINE TYPE

5.1. Overview By Vaccine Type
5.2. Historical and Forecast Data Analysis By Vaccine Type
5.3. Tetanus Toxoid (Tt) Historic and Forecast Sales By Regions
5.4. Diphtheria And Tetanus (Dt) Historic and Forecast Sales By Regions
5.5. Tetanus And Diphtheria (Td) Historic and Forecast Sales By Regions
5.6. Diphtheria, Tetanus, And Pertussis (Dtap) Historic and Forecast Sales By Regions
5.7. Tetanus, Diphtheria, And Pertussis (Tdap) Historic and Forecast Sales By Regions
5.8. Diphtheria, Tetanus, Pertussis, Hib And Hepatitis B (Dtp-Hib-Hepb) Historic and Forecast Sales By Regions
5.9. Pentavalent (Dtap-Ipv/Hib) Historic and Forecast Sales By Regions
5.10. Hexavalent (Dtap-Ipv/Hib-Hepb) Historic and Forecast Sales By Regions
5.11. Other Vaccine Types Historic and Forecast Sales By Regions

6. GLOBAL TETANUS TOXOID VACCINE MARKET ANALYSIS BY AGE GROUP

6.1. Overview By Age Group
6.2. Historical and Forecast Data Analysis By Age Group
6.3. Pediatric Historic and Forecast Sales By Regions
6.4. Adult Historic and Forecast Sales By Regions

7. GLOBAL TETANUS TOXOID VACCINE MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data Analysis By End-Use
7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
7.4. Government Organizations Historic and Forecast Sales By Regions
7.5. Other End-Users Historic and Forecast Sales By Regions

8. GLOBAL TETANUS TOXOID VACCINE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE TETANUS TOXOID VACCINE COMPANIES

9.1. Tetanus Toxoid Vaccine Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF TETANUS TOXOID VACCINE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Bharat Biotech International Limited
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Biological E. Limited
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Biological Products Institute (BPI) Argentina
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Chengdu Institute Of Biological Products Co. Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. GlaxoSmithKline
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Johnson & Johnson
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Merck & Co. Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Mitsubishi Tanabe Pharma Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Panacea Biotec
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Pfizer Inc.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Sanofi
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Serum Institute Of India
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Zydus Group
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Vaccine Type (USD MN)
Tetanus Toxoid (Tt) Market Sales By Geography (USD MN)
Diphtheria And Tetanus (Dt) Market Sales By Geography (USD MN)
Tetanus And Diphtheria (Td) Market Sales By Geography (USD MN)
Diphtheria, Tetanus, And Pertussis (Dtap) Market Sales By Geography (USD MN)
Tetanus, Diphtheria, And Pertussis (Tdap) Market Sales By Geography (USD MN)
Diphtheria, Tetanus, Pertussis, Hib And Hepatitis B (Dtp-Hib-Hepb) Market Sales By Geography (USD MN)
Pentavalent (Dtap-Ipv/Hib) Market Sales By Geography (USD MN)
Hexavalent (Dtap-Ipv/Hib-Hepb) Market Sales By Geography (USD MN)
Other Vaccine Types Market Sales By Geography (USD MN)
Analysis By Age Group (USD MN)
Pediatric Market Sales By Geography (USD MN)
Adult Market Sales By Geography (USD MN)
Analysis By End-Use (USD MN)
Hospitals And Clinics Market Sales By Geography (USD MN)
Government Organizations Market Sales By Geography (USD MN)
Other End-Users Market Sales By Geography (USD MN)
Global Tetanus Toxoid Vaccine Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Tetanus Toxoid Vaccine Report
Market Research Process
Market Research Methodology
Global Tetanus Toxoid Vaccine Market Size, By Regions (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Vaccine Type
Market Attractiveness Analysis By Age Group
Market Attractiveness Analysis By End-Use
Market Attractiveness Analysis By Regions
Value Chain Analysis
Global Market Analysis By Vaccine Type (USD MN)
Tetanus Toxoid (Tt) Market Sales By Geography (USD MN)
Diphtheria And Tetanus (Dt) Market Sales By Geography (USD MN)
Tetanus And Diphtheria (Td) Market Sales By Geography (USD MN)
Diphtheria, Tetanus, And Pertussis (Dtap) Market Sales By Geography (USD MN)
Tetanus, Diphtheria, And Pertussis (Tdap) Market Sales By Geography (USD MN)
Diphtheria, Tetanus, Pertussis, Hib And Hepatitis B (Dtp-Hib-Hepb) Market Sales By Geography (USD MN)
Pentavalent (Dtap-Ipv/Hib) Market Sales By Geography (USD MN)
Hexavalent (Dtap-Ipv/Hib-Hepb) Market Sales By Geography (USD MN)
Other Vaccine Types Market Sales By Geography (USD MN)
Global Market Analysis By Age Group (USD MN)
Pediatric Market Sales By Geography (USD MN)
Adult Market Sales By Geography (USD MN)
Global Market Analysis By End-Use (USD MN)
Hospitals And Clinics Market Sales By Geography (USD MN)
Government Organizations Market Sales By Geography (USD MN)
Other End-Users Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis